Expertise in
18
conditions

Jasmin B. Deschner-Kuemmerle

Hoppe Seyler Str. 9, 
Tuebingen, BW, DE 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
18
conditions
Hoppe Seyler Str. 9, 
Tuebingen, BW, DE 

Overview

Jasmin Deschner-Kuemmerle practices practicing medicine in Tuebingen, Germany.

Ms. Deschner-Kuemmerle is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Familial Cold Autoinflammatory Syndrome, Neonatal Onset Multisystem Inflammatory Disease, Muckle-Wells Syndrome, and Mevalonate Kinase Deficiency.

She is actively involved in clinical research, co-authoring 136 peer reviewed articles and participating in 2 clinical trials.

Gender

Female

Locations

Hoppe Seyler Str. 9, Tuebingen, BW 72076, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3 Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients From 1 Year to <18 Years of Age With Juvenile Idiopathic Arthritis (JIA)
A Phase 3 Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients From 1 Year to <18 Years of Age With Juvenile Idiopathic Arthritis (JIA)
Enrollment Status: Recruiting
Publish Date: August 24, 2026
Intervention Type: Drug
Study Drug: Baricitnib
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled, Withdrawal, Safety and Efficacy Study of Oral Baricitinib in Patients From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic Arthritis (JIA)
A Randomized, Double-Blind, Placebo-Controlled, Withdrawal, Safety and Efficacy Study of Oral Baricitinib in Patients From 2 Years to Less Than 18 Years Old With Juvenile Idiopathic Arthritis (JIA)
Enrollment Status: Completed
Publish Date: October 07, 2022
Intervention Type: Drug
Study Drug: Baricitnib
Study Phase: Phase 3
View 1 Less Clinical Trial

136 Total Publications

Truncating RELA variants drive autoinflammation and autoimmunity by impairing the negative feedback control of NF-κB.
Truncating RELA variants drive autoinflammation and autoimmunity by impairing the negative feedback control of NF-κB.
Journal: JCI insight
Published: August 11, 2026

Frequently Asked Questions about Jasmin B. Deschner-Kuemmerle

Is Jasmin B. Deschner-Kuemmerle a top-rated expert for Familial Cold Autoinflammatory Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Jasmin B. Deschner-Kuemmerle is classified as an Elite expert for Familial Cold Autoinflammatory Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Jasmin B. Deschner-Kuemmerle participate in research or clinical trials?

Yes. Jasmin B. Deschner-Kuemmerle has published 136 articles and abstracts on conditions like Familial Cold Autoinflammatory Syndrome. You can view a list of Jasmin B. Deschner-Kuemmerle's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Deschner-Kuemmerle's expertise for a condition
ConditionClose
View All 8 Elite Conditions
View All 7 Advanced Conditions
View All 31 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile